Table of Contents

Reprod. Med., Volume 1, Issue 1 (December 2020) – 2 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Readerexternal link to open them.
Order results
Result details
Select all
Export citation of selected articles as:
Open AccessEditorial
Reproductive Medicine—An Interdisciplinary Open Access Journal for an Interdisciplinary and Growing Community
Reprod. Med. 2020, 1(1), 15-16; https://doi.org/10.3390/reprodmed1010002 (registering DOI) - 25 Feb 2020
Viewed by 144
Abstract
The journal Reproductive Medicine just started as an open access journal with an excellent editorial team. As founding editor-in-chief it is my belief that this new journal will find its specific niche in the field of reproduction. It is not only the free [...] Read more.
The journal Reproductive Medicine just started as an open access journal with an excellent editorial team. As founding editor-in-chief it is my belief that this new journal will find its specific niche in the field of reproduction. It is not only the free access to scientific data that is very important today and that comes with this journal; this journal also builds the bridge between IVF (In Vitro Fertilization) and ART (Assisted Reproductive Technology) on the one hand and pregnancy and pregnancy pathologies on the other hand, combined in one journal. This interdisciplinary approach is needed as the last decade has shown that there are more links between the mode of conception and the outcome of pregnancy than we ever thought. We encourage our readers to scroll through the list of papers that will be published in this journal to open their view for all aspects of reproduction from the ovarian reserve to the epigenetic changes of a newborn due to fetal programming. Full article
Open AccessArticle
Systematic Development, Validation and Optimization of a Human Embryo Culture System
Reprod. Med. 2020, 1(1), 1-14; https://doi.org/10.3390/reprodmed1010001 - 30 Jan 2020
Viewed by 104
Abstract
Objective: To develop and validate a reliable in vitro culture system for human embryos. Design: Retrospective analyses of a series of four studies were conducted between 2006 and 2010 to assess the effect of incubator type (CO2 box versus Tri-gas minibox), media [...] Read more.
Objective: To develop and validate a reliable in vitro culture system for human embryos. Design: Retrospective analyses of a series of four studies were conducted between 2006 and 2010 to assess the effect of incubator type (CO2 box versus Tri-gas minibox), media type, oil type, and hyaluronate supplementation. Optimization of in vitro blastocyst development was verified by assessing our National CDC/ART Surveillance reports between 2010 and 2016. Material and Methods: All patients experienced controlled ovarian hyperstimulation, followed by egg retrieval 35 h post-hCG. Cumulus-oocyte complexes were temporarily cultured in P1 or LG Fert medium plus HSA. Eggs were moved to a more complex media (G-medium or Global®-LG medium) containing a synthetic protein and embryo adhesion supplement (SPS and EAS, respectively; mLG) post-ICSI insemination. Zygotes were assigned to group culture in 25 µl droplets under oil (light mineral oil or paraffin oil; 37 °C) and embryo development was evaluated on Days 3, 5, and 6 and transferred on Day 3 to 5 depending on the number/quality of embryos available and the IVF history of the patient. Transfers were performed under ultrasound guidance, primarily using a Sureview-Wallace catheter, and enriched ET medium containing 500 µg/mL EAS. Results: Pilot study results (Expt. 1) showed that a mLG single-step medium could be effectively used in combination with Sanyo MCO-5 tri-gas (TG) incubators. Once adapted to SCIRS Lab in 2007 (Expt. 2), the latter culture system yielded improved blastocyst production and pregnancy outcomes compared to CO2 in air sequential incubation in P1/Multi-blast medium. In Expt. 3, the mLG/TG system yielded high levels of ≥2BB quality blastocysts (51 to 66%) across all age groups, and greater (p < 0.05) pregnancy success/live birth rates using fewer embryos transferred on Day 5 versus Day 3. After validating its clinical effectiveness, mLG was then prospectively compared to a new generation G-media (1.5 & 2.5; Expt. 4) and determined that the crossover treatment using paraffin oil (Ovoil™) allowed the mLG system to be optimized. Subsequently, a compilation of our Annual CDC/ART reported data over six years verified the overall viability of in vitro cultured and vitrified blastocysts produced in the mLG/TG system. Conclusion: By systematically evaluating and implementing various components of an embryo culture system we were able to optimize blastocyst development over the last decade. Our mLG/TG culture system modified an exceptionally well designed KSOMAA LG medium using endotoxin-free EAS and SPS additives to support cellular membrane wellness under stressful in vitro conditions (e.g., culture, cell biopsy, vitrification). Our use of the mLG/TG culture system has proven to be effective, creating reliably high blastocyst production, implantation, and healthy live births. Full article
Back to TopTop